ANAVEX LIFE SCIENCES CORP. (AVXL)
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
Address
630 5TH AVENUE
NEW YORK, NY 10111
Founded
2004
Number of Employees
40
Website
http://www.anavex.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)